期刊文献+

近5年我院就诊恶性肿瘤患者口服中枢性镇痛药应用分析 被引量:1

Use of Oral Central Analgesics in Cancerous Patients in Guangdong Provincial People's Hospital During 2005-2010 Period
暂未订购
导出
摘要 目的:了解我院近5年来口服中枢性镇痛药使用情况并分析其趋势,为防止药物滥用、科学管理及临床合理使用提供参考。方法:通过医院HIS系统提取2005—2010年每年第4季度我院口服中枢性镇痛药各品种的总用量、使用总天数、恶性肿瘤患者总病例数等数据资料,同时以WHO推荐的限定日剂量(DDD)、用药频率(DDDs)、药物利用指数(DUI)等为指标进行统计分析。结果:我院就诊恶性肿瘤患者病例数逐年增加;使用量方面,羟考酮缓释片、弱阿片类和吗啡片使用量逐年增加,而吗啡控释片呈下降趋势。其药物利用指数为:弱阿片类、小规格羟考酮控释片及吗啡片DUI<1,吗啡控释片、较大规格羟考酮缓、控释片DUI>1。结论:我院口服中枢性镇痛药使用基本合理,不存在滥用现象。 OBJECTIVE: To evaluate the status quo and tendency of the use of oral central analgesics in recent 5 years(2005-2010) in our hospital for clinical references in preventing drug abuse,scientific management and clinical rational use.METHODS: The data including total consumption amount and number of days of analgesic use and total number of cancerous patients etc in our hospital between 2005 and 2010 were retrieved from hospital HIS system and statistically analyzed by using defined daily dose(DDD),DDDs and drug utilization index(DUI) and so on recommended by WHO as indexes.RESULTS: The number of cancerous patients seen in our hospital increased year by year.The consumption amount of oxycodone extended-release tablets,weak opioids and morphine tablets increased year by year,while that of the controlled-release morphine tablets showed a declining trend.DUI1 was noted in weak opioid,small specification of oxycodone sustained-release tablets and morphine tablets while DUI1 in morphine controlled-release tablets and the larger size oxycodone extended release tablets.CONCLUSION: The use of oral analgesics in our hospital was rational on the whole without presence of drug abuse phenomenon.
出处 《中国医院用药评价与分析》 2011年第12期1095-1098,共4页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 口服中枢性镇痛药 限定日剂量 用药频率 药物利用指数 Oral central analgesics drugs Defined daily dose(DDD) DDDs Drug utilization index
  • 相关文献

参考文献4

二级参考文献24

  • 1张可贤,王志仪.癌痛治疗新概念——细胞镇痛、基因治疗[J].四川肿瘤防治,2005,18(3):203-205. 被引量:9
  • 2张河.癌症疼痛的中医药治疗进展[J].天津中医学院学报,2006,25(1):51-52. 被引量:6
  • 3Cleeland C S, Gonin R, Hatfield A K, et al. Pain and its treatment in outpatients with metastatic cancer[J].N Eugl J Med, 1994, 330(9) :592 - 596.
  • 4周际昌.实用肿瘤内科学[M].2版.北京:人民卫生出版社,2002:218-220.
  • 5谭冠先,郑宝森.癌症治疗手册[M].郑州:郑州大学出版社,2003:164.
  • 6Hanks G W, Conno F, Cherny N, et al. Morphine and ahernative opioids in cancer pain:the EAPC recommendations [ J ]. Br J Cancer,2001,84(5) :587 - 593.
  • 7Bercovitch M, Adunsky A. High dose controlled - release oxycodone in hospice care[J]. J Pain Palliat Care Pharmacother,2006,20(4) : 33 - 39.
  • 8Riley J, Eisenberg E, Muller - Schwefe G, et al. Oxycodone: a review of its use in the management of pain [J]. Curr Med Res Opin,2008,24( 1 ) :175 - 192.
  • 9Citron M L,Kaplan R,Parris W C,et al. Long - term administration of controlled - release oxycodone tablets for the treatment of cancer pain[J].Cancer Invest,1998,16(8) :562 - 571.
  • 10Mucci - LoRusso P,Berman B S,Silberstein P T,et al. Controlled - release oxycodone compared with controlled - release morphine in the treatment of cancer pain:a randomized, double - blind, parallel - group study[J]. Eur J Pain,1998,2(3) :239 - 249.

共引文献23

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部